Chengwang Xu

964 total citations
19 papers, 810 citations indexed

About

Chengwang Xu is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Chengwang Xu has authored 19 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Physiology. Recurrent topics in Chengwang Xu's work include MicroRNA in disease regulation (7 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Chengwang Xu is often cited by papers focused on MicroRNA in disease regulation (7 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Chengwang Xu collaborates with scholars based in China, United States and Italy. Chengwang Xu's co-authors include Hanjiang Fu, Xiaofei Zheng, Yi Tie, Zhixian Sun, Ruiyun Xing, Jie Zhu, Hong Jiang, Jie Zhu, Zhuoyuan Zhang and Yingxu Shi and has published in prestigious journals such as Blood, PLoS ONE and The FASEB Journal.

In The Last Decade

Chengwang Xu

19 papers receiving 806 citations

Peers

Chengwang Xu

HEMAT

IMMUN

SURGE

Vitalba Ruggieri Italy

Lan Dai China

Lixiang Wang China

Sang‐Woo Kim South Korea

Luciana Pizzatti Brazil

Chia‐Wei Chang United States

Yang Han China

Jie Shi China

Jing‐Yu Lang China

Vitalba Ruggieri Italy

Chengwang Xu

374 ×0.6

187 ×0.4

89 ×1.0

HEMAT

65 ×1.2

IMMUN

52 ×1.0

SURGE

Citations per year, relative to Chengwang Xu Chengwang Xu (= 1×) peers Vitalba Ruggieri

Countries citing papers authored by Chengwang Xu

Since Specialization

Citations

This map shows the geographic impact of Chengwang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengwang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengwang Xu more than expected).

Fields of papers citing papers by Chengwang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengwang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengwang Xu. The network helps show where Chengwang Xu may publish in the future.

Co-authorship network of co-authors of Chengwang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengwang Xu. A scholar is included among the top collaborators of Chengwang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengwang Xu. Chengwang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dong, Xiaoming, Ke Zhao, Chengwang Xu, et al.. (2020). EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome. The FASEB Journal. 34(6). 8416–8427. 10 indexed citations

Zou, Pan, Shoujun Yuan, Xin Yang, et al.. (2019). Structural characterization and antitumor effects of chitosan oligosaccharides against orthotopic liver tumor via NF-κB signaling pathway. Journal of Functional Foods. 57. 157–165. 26 indexed citations

Yang, Jun, Linna Li, Chengwang Xu, et al.. (2018). CT‑1042, a novel anticancer agent, exhibits effects by activating p53 and inhibiting survivin. Oncology Reports. 39(6). 2759–2768. 4 indexed citations

Wang, Ying, Shoujun Yuan, Linna Li, et al.. (2017). Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo. Oncology Letters. 13(6). 4762–4768. 5 indexed citations

Guo, Wanjun, Linna Li, Chengwang Xu, et al.. (2015). Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo. PLoS ONE. 10(2). e0116202–e0116202. 62 indexed citations

Li, Linna, Dexuan Yang, Jia Na, et al.. (2014). Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors. Anti-Cancer Drugs. 25(8). 857–867. 12 indexed citations

Xuan, Zixue, Qi Zhang, Chengwang Xu, et al.. (2014). Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth. International Journal of Oncology. 45(6). 2411–2420. 10 indexed citations

Zheng, Weiwei, Xiaoming Dong, Rong‐Hua Yin, et al.. (2014). EDAG Positively Regulates Erythroid Differentiation and Modifies GATA1 Acetylation Through Recruiting p300. Stem Cells. 32(8). 2278–2289. 27 indexed citations

Dou, Liping, Jingxin Li, Yonghui Li, et al.. (2013). MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Molecular Biology Reports. 40(12). 6811–6819. 23 indexed citations

10.

Liping, et al.. (2013). MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia. OncoTargets and Therapy. 6. 1153–1153. 8 indexed citations

11.

Li, Yonghui, Li Gao, Xufeng Luo, et al.. (2012). Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood. 121(3). 499–509. 141 indexed citations

12.

Xu, Chengwang, Yang Yang, Yi‐Qun Zhan, et al.. (2012). Erythroid differentiation‐associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis. FEBS Journal. 279(16). 2848–2862. 13 indexed citations

13.

Li, Jipeng, Hanjiang Fu, Chengwang Xu, et al.. (2010). miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer. 10(1). 354–354. 127 indexed citations

14.

Ding, Yali, Chengwang Xu, Yi‐Qun Zhan, et al.. (2010). Over‐expression of EDAG in the myeloid cell line 32D: Induction of GATA‐1 expression and erythroid/megakaryocytic phenotype. Journal of Cellular Biochemistry. 110(4). 866–874. 9 indexed citations

15.

Xu, Chengwang, Shanshan Liu, Hanjiang Fu, et al.. (2010). MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. European Journal of Cancer. 46(15). 2828–2836. 128 indexed citations

16.

Dou, Liping, et al.. (2010). [Targeted regulation of mll-af4 fusion gene by miR-142-3p].. PubMed. 18(6). 1595–9. 1 indexed citations

17.

Fu, Hanjiang, Yi Tie, Chengwang Xu, et al.. (2005). Identification of human fetal liver miRNAs by a novel method. FEBS Letters. 579(17). 3849–3854. 173 indexed citations

18.

Zhou, Ying, Wang‐Xiang Xu, Yi‐Qun Zhan, et al.. (2004). [Expression of EDAG-1 gene in human leukemia and lymphoma cell lines].. PubMed. 23(11). 1238–43. 4 indexed citations

19.

Zhan, Yi‐Qun, Wang‐Xiang Xu, Chang‐Yan Li, et al.. (2003). Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-κB. Journal of Hepatology. 40(3). 391–398. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact